01 / Vendor Profile
ARISAN THERAPEUTICS INC Federal Contracts and Awards
UEI PYRKTQPNVJZ8 · CAGE 616D2
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $5.58M in net contract obligations to ARISAN THERAPEUTICS INC across 15 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
ARISAN THERAPEUTICS INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$3.69M
FY 2023ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $263.6K | 6 | 1 | — |
| FY 2021 | $857.1K | 2 | 1 | +225.2% |
| FY 2022 | $769.4K | 4 | 1 | −10.2% |
| FY 2023 | $3.69M | 3 | 2 | +379.9% |
04 / Federal Customers
Which federal agencies buy from ARISAN THERAPEUTICS INC?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $3.69M | 1 | 66.1% | |
| 2100 | $1.89M | 14 | 33.9% |
05 / Contracting Offices
Which contracting offices buy from ARISAN THERAPEUTICS INC?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $3.69M | 1 | 66.1% | |
| W911SR | DEPT OF THE ARMY | $1.63M | 8 | 29.1% | |
| W911QY | DEPT OF THE ARMY | $263.6K | 6 | 4.7% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $3.69M | 1 | 1 | 66.1% |
| AN14 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | $1.10M | 4 | 1 | 19.7% |
| AJ15 | GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D FACILITIES & MAJ EQUIP | $526.8K | 4 | 1 | 9.4% |
| AD25 | R&D- DEFENSE OTHER: SERVICES (OPERATIONAL SYSTEMS DEVELOPMENT) | $263.6K | 6 | 1 | 4.7% |
08 / Competition Pattern
How was ARISAN THERAPEUTICS INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for ARISAN THERAPEUTICS INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N93023C00051 | Sep 18, 2023 | $3.69M | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIAID | 541715 | AN12 |
10 / Interpreting the Profile
How should you evaluate ARISAN THERAPEUTICS INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.